FitLife Brands (FTLF) Competitors $20.12 +0.07 (+0.32%) As of 10:14 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock FTLF vs. NRIX, DAWN, TBPH, OLMA, TYRA, TERN, SNDL, GYRE, ARVN, and ERASShould you be buying FitLife Brands stock or one of its competitors? The main competitors of FitLife Brands include Nurix Therapeutics (NRIX), Day One Biopharmaceuticals (DAWN), Theravance Biopharma (TBPH), Olema Pharmaceuticals (OLMA), Tyra Biosciences (TYRA), Terns Pharmaceuticals (TERN), SNDL (SNDL), Gyre Therapeutics (GYRE), Arvinas (ARVN), and Erasca (ERAS). These companies are all part of the "pharmaceutical products" industry. FitLife Brands vs. Its Competitors Nurix Therapeutics Day One Biopharmaceuticals Theravance Biopharma Olema Pharmaceuticals Tyra Biosciences Terns Pharmaceuticals SNDL Gyre Therapeutics Arvinas Erasca Nurix Therapeutics (NASDAQ:NRIX) and FitLife Brands (NASDAQ:FTLF) are both small-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their earnings, risk, profitability, dividends, valuation, media sentiment, analyst recommendations and institutional ownership. Which has more volatility & risk, NRIX or FTLF? Nurix Therapeutics has a beta of 2.33, indicating that its stock price is 133% more volatile than the S&P 500. Comparatively, FitLife Brands has a beta of 0.65, indicating that its stock price is 35% less volatile than the S&P 500. Do analysts rate NRIX or FTLF? Nurix Therapeutics currently has a consensus target price of $29.07, suggesting a potential upside of 187.98%. FitLife Brands has a consensus target price of $23.00, suggesting a potential upside of 14.29%. Given Nurix Therapeutics' higher possible upside, equities research analysts plainly believe Nurix Therapeutics is more favorable than FitLife Brands.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nurix Therapeutics 1 Sell rating(s) 3 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.76FitLife Brands 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is NRIX or FTLF more profitable? FitLife Brands has a net margin of 12.63% compared to Nurix Therapeutics' net margin of -234.57%. FitLife Brands' return on equity of 21.70% beat Nurix Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Nurix Therapeutics-234.57% -45.26% -34.71% FitLife Brands 12.63%21.70%13.45% Do institutionals and insiders hold more shares of NRIX or FTLF? 2.3% of FitLife Brands shares are owned by institutional investors. 7.4% of Nurix Therapeutics shares are owned by company insiders. Comparatively, 61.4% of FitLife Brands shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the media favor NRIX or FTLF? In the previous week, FitLife Brands had 1 more articles in the media than Nurix Therapeutics. MarketBeat recorded 3 mentions for FitLife Brands and 2 mentions for Nurix Therapeutics. Nurix Therapeutics' average media sentiment score of 0.74 beat FitLife Brands' score of 0.42 indicating that Nurix Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nurix Therapeutics 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive FitLife Brands 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Which has preferable valuation & earnings, NRIX or FTLF? FitLife Brands has higher revenue and earnings than Nurix Therapeutics. Nurix Therapeutics is trading at a lower price-to-earnings ratio than FitLife Brands, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNurix Therapeutics$54.55M14.15-$193.57M-$2.61-3.87FitLife Brands$64.47M2.93$8.98M$0.8423.96 SummaryFitLife Brands beats Nurix Therapeutics on 11 of the 16 factors compared between the two stocks. Get FitLife Brands News Delivered to You Automatically Sign up to receive the latest news and ratings for FTLF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding FTLF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart FTLF vs. The Competition Export to ExcelMetricFitLife BrandsMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$188.97M$10.69B$6.14B$10.60BDividend YieldN/A1.86%5.70%4.74%P/E Ratio23.9622.2885.6726.93Price / Sales2.9328.41621.78136.94Price / Cash19.4925.4437.7861.77Price / Book5.123.4513.116.70Net Income$8.98M$210.63M$3.30B$276.44M7 Day Performance2.16%1.97%4.37%2.94%1 Month Performance5.20%2.65%9.02%9.40%1 Year Performance23.16%-4.83%86.98%35.23% FitLife Brands Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)FTLFFitLife Brands3.9572 of 5 stars$20.13+0.3%$23.00+14.3%+21.6%$188.97M$64.47M23.9620News CoverageAnalyst UpgradeNRIXNurix Therapeutics2.1003 of 5 stars$9.74-2.1%$29.07+198.5%-54.4%$744.23M$88.38M-3.73300Upcoming EarningsDAWNDay One Biopharmaceuticals3.0506 of 5 stars$7.23-1.0%$25.29+249.9%-45.4%$741.08M$131.16M-7.6260Positive NewsTBPHTheravance Biopharma3.3331 of 5 stars$14.40-1.2%$23.00+59.7%+78.3%$727.72M$77.21M60.21110OLMAOlema Pharmaceuticals2.8415 of 5 stars$10.44-5.6%$24.00+129.9%-7.9%$716.29MN/A-5.2770News CoverageAnalyst ForecastTYRATyra Biosciences2.3208 of 5 stars$13.39-0.3%$31.86+138.0%-35.8%$713.42MN/A-7.5220TERNTerns Pharmaceuticals3.8421 of 5 stars$8.07-4.3%$15.49+91.9%+1.8%$707.52MN/A-7.7740SNDLSNDL3.1302 of 5 stars$2.67+4.1%$4.50+68.9%+35.2%$702.94M$671.81M-9.912,516GYREGyre Therapeutics1.3217 of 5 stars$7.27-1.0%$18.00+147.8%-43.9%$699.79M$105.76M727.3340ARVNArvinas3.006 of 5 stars$9.27-3.7%$16.29+75.8%-63.2%$680.95M$372.80M-9.18420Analyst ForecastERASErasca2.6552 of 5 stars$2.42+3.6%$3.71+53.8%+1.6%$676.55MN/A-5.30120High Trading Volume Related Companies and Tools Related Companies Nurix Therapeutics Competitors Day One Biopharmaceuticals Competitors Theravance Biopharma Competitors Olema Pharmaceuticals Competitors Tyra Biosciences Competitors Terns Pharmaceuticals Competitors SNDL Competitors Gyre Therapeutics Competitors Arvinas Competitors Erasca Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:FTLF) was last updated on 10/8/2025 by MarketBeat.com Staff From Our PartnersBuilding The Infrastructure for the Coming Financial ResetWhile China pushes nearly $1 trillion through its new digital currency, one emerging company is quietly buildi...Intellistake | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredThe Dollar’s Crashing—What Are You Doing About It?The U.S. dollar is down 10.8%—its steepest drop since 1973. As global confidence in the dollar fades, centr...Lear Capital | SponsoredIf You Keep Cash In A U.S. Bank Account… Read This NOWThe Treasury Department just issued a stunning warning: U.S. banks could lose up to $6.6 trillion of custom...Banyan Hill Publishing | SponsoredThis is the “End of Tesla” as we know it…Jeff has identified five of the past seven number-one performing tech stocks — before they took off. His Tesla...Brownstone Research | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | Sponsored1 Hour Once A DayMy top income trading expert, Dave Aquino, just released a 1-hour trading strategy designed specifically to he...Base Camp Trading | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding FitLife Brands Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share FitLife Brands With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
